Alzheimer's Society Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2003
NCT00142324
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alzheimer's Society